Quick Answer
Pharma-Bio Serv, Inc. reported Cash and Equivalents of $14.46 million for fiscal year 2022.
Pharma-Bio Serv, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $14.46M | -17.2% |
| 2021 | $17.47M | +1.9% |
| 2020 | $17.14M | +10.6% |
| 2019 | $15.49M | -3.4% |
| 2018 | $16.03M | +38.3% |
| 2017 | $11.59M | -15.8% |
| 2016 | $13.77M | -7.5% |
| 2015 | $14.89M | -1.3% |
| 2014 | $15.09M | +25.3% |
| 2013 | $12.05M | +84.2% |
| 2012 | $6.54M | +51.5% |
| 2011 | $4.32M | +86.3% |
| 2010 | $2.32M | +12.9% |
| 2009 | $2.05M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| July 31, 2023 | $2.87M | -79.8% | -64.6% |
| April 30, 2023 | $8.10M | -38.5% | -44.0% |
| October 31, 2022 | $14.46M | -17.2% | +1.6% |
| July 31, 2022 | $14.24M | -13.7% | +8.2% |
| April 30, 2022 | $13.16M | -18.1% | -14.2% |
| January 31, 2022 | $15.35M | -19.2% | -12.1% |
| October 31, 2021 | $17.47M | +1.9% | +5.9% |
| July 31, 2021 | $16.50M | -1.9% | +2.7% |
- Pharma-Bio Serv, Inc. showed a decrease of -17.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2022 period, Pharma-Bio Serv, Inc.’s cash and equivalents has grown by 604.9% (from $2.05 million to $14.46 million).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on January 30, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: